Glenmark Pharmaceutical launches Tiogiva in UK for COPD treatment

Glenmark Pharmaceutical launches Tiogiva in UK for COPD treatment

(adsbygoogle = window.adsbygoogle || []).push({}); Glenmark Pharmaceutical has announced the UK launch of Tiogiva, a bioequivalent version of Tiotropium Bromide dry powder inhaler (DPI), for the treatment of chronic obstructive pulmonary disease (COPD). Tiotropium Bromide DPI is a bioequivalent version of Boehringer Ingelheim’s Spiriva More...

by businessnewstoday | Published 2 days ago
Cipla associate Avenue Therapeutics fails to get FDA approval for IV tramadol
By businessnewstoday On Tuesday, June 15th, 2021
0 Comments

Cipla associate Avenue Therapeutics fails to get FDA approval for IV tramadol

Cipla’s step-down associate firm Avenue Therapeutics has failed to get approval from the US Food and Drug Administration (FDA) for IV tramadol as an alternative for reducing the use of conventional opioids in More...

US FDA issues warning letter to Lupin Limited over its manufacturing facility in Somerset, New Jersey
By businessnewstoday On Monday, June 14th, 2021
0 Comments

Lupin Limited gets FDA warning letter for Lupin Somerset site

Indian pharma company Lupin Limited said that it has been issued a warning letter from the US Food and Drug Administration (FDA) for its manufacturing facility in Somerset, New Jersey. The warning letter follows More...

ImmVira wraps up first dosing for MVR-T3011 in phase 2 trials in US and China
By businessnewstoday On Sunday, June 13th, 2021
0 Comments

ImmVira wraps up first dosing for MVR-T3011 in US and China

ImmVira said that it has wrapped up the first dosing of its oncolytic virus product – MVR-T3011 intratumoral injection in phase 2 clinical trials both in China and the US. According to the Chinese pharma company, More...

AbbVie reported that ibrutinib, venetoclax combo has met the primary endpoint of PFS in phase 3 GLOW study in chronic lymphocytic leukemia
By businessnewstoday On Sunday, June 13th, 2021
0 Comments

AbbVie’s ibrutinib, venetoclax combo succeeds in phase 3 GLOW study

AbbVie said that the phase 3 GLOW study in chronic lymphocytic leukemia (CLL) investigating the combination of IMBRUVICA (ibrutinib) plus VENCLEXTA/VENCLYXTO (venetoclax) (I+V) has met its primary endpoint of superior More...

Suven Pharmaceuticals partners with CSIR-IICT to manufacture Molnupiravir and 2-DG
By businessnewstoday On Thursday, June 10th, 2021
0 Comments

Suven Pharma partners with CSIR-IICT to manufacture Molnupiravir and 2-DG

Suven Pharmaceuticals (Suven Pharma), CSIR-Indian Institute of Chemical Technology (IICT), Hyderabad and CSIR-National Institute of Interdisciplinary Science & Technology, Thiruvananthapuram have forged an agreement More...

Glenmark Pharmaceuticals reports positive interim data from PMS study on Covid-19 drug Favipiravir
By businessnewstoday On Wednesday, June 9th, 2021
0 Comments

Glenmark reports positive interim data from PMS study on Favipiravir

Glenmark Pharmaceuticals said that interim data from its post marketing surveillance (PMS) study on Favipiravir (FabiFlu) in India supports the Covid-19 drug’s safety and effectiveness in real world settings. Besides, More...

Lupin Limited gets FDA approval for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets
By businessnewstoday On Monday, June 7th, 2021
0 Comments

Lupin Limited gets FDA nod for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets

Lupin Limited (Lupin) said it has secured approval for its Emtricitabine and Tenofovir Disoproxil Fumarate Tablets, 200 mg/300 mg, from the US Food and Drug Administration (FDA). Emtricitabine and Tenofovir Disoproxil More...

Lupin Limited launches generic of Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL in US
By businessnewstoday On Friday, June 4th, 2021
0 Comments

Lupin Limited launches generic of Arformoterol Tartrate in US

Lupin Limited said that it has launched the authorized generic version of Brovana (arformoterol tartrate) Inhalation Solution 15 mcg /2 mL, unit-dose vials, of Sunovion Pharmaceuticals, in the US. Arformoterol Tartrate More...

Glenmark Pharmaceuticals gets FDA approval for Theophylline Extended-Release Tablets generic
By businessnewstoday On Friday, June 4th, 2021
0 Comments

Glenmark gets FDA nod for Theophylline Extended-Release Tablets generic

Glenmark Pharmaceuticals has secured final approval from the US Food and Drug Administration (FDA) for Theophylline Extended-Release Tablets, 300 mg, and 450 mg. The Indian pharma company’s Theophylline Extended-Release More...